Insider · CIK 0001633927
Vincent S LoPriore
Files at HEPA (Hepion Pharmaceuticals, Inc.), CNTN (Canton Strategic Holdings, Inc.). First filing Apr 27, 2026, latest Apr 27, 2026.
Vincent S LoPriore files SEC Form 4 as chair, director and 10% owner at HEPA (Hepion Pharmaceuticals, Inc.), and also at CNTN (Canton Strategic Holdings, Inc.). Since Apr 27, 2026, Vincent S LoPriore has reported 1 open-market buy worth $250k and 0 open-market sells worth $0, the latest filed on Apr 27, 2026.
A track record needs three past buys with six months of prices behind them; Vincent S LoPriore has 0, so none is measured yet.
The newest scored trade: bought $250k of HEPA on Apr 21, 2026, filed Apr 27, 2026, scored 64 (notable). In the last 12 months: 1 buy worth $250k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
HEPA: Hepion Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 64Notable | Hepion Pharmaceuticals, Inc. | $250k 6,250,000 shares | - | +14% from low-90% from high |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | HEPA Hepion Pharmaceuticals, Inc. | POpen-market purchase Warrantsderivativeindirect: By Gravitas Capital LP | +12,500,000 | $0.00 | $0 | 22,500,000 | 29 d ago |
| Apr 21, 2026 | HEPA Hepion Pharmaceuticals, Inc. | POpen-market purchase Common Stock, par value $0.0001 per shareindirect: By Gravitas Capital LP | +5,000,000 | $0.04 | $200k | 5,000,000 | Apr 27, 2026 |
| Apr 21, 2026 | HEPA Hepion Pharmaceuticals, Inc. | POpen-market purchase Common Stock, par value $0.0001 per shareindirect: By Invictus Capital Advisors Pension Plan | +1,250,000 | $0.04 | $50k | 6,250,000 | Apr 27, 2026 |
| Nov 3, 2025 | CNTN Canton Strategic Holdings, Inc. | AGrant or award Stock Optionderivative | +90,000 | $0.00 | $0 | 190,000 | Nov 5, 2025 |
Questions about Vincent S LoPriore
Answered from the filings on this page, as of the latest one.
Is Vincent S LoPriore buying or selling?
In the last 12 months Vincent S LoPriore reported 1 open-market buy worth $250k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $250k of HEPA on Apr 21, 2026. Grants, option exercises and tax withholding are not counted.
How did Vincent S LoPriore's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Vincent S LoPriore has 0.
Where does Vincent S LoPriore file Form 4?
Vincent S LoPriore has filed Form 4 at HEPA (Hepion Pharmaceuticals, Inc.) as Executive Chairman; CNTN (Canton Strategic Holdings, Inc.) as Executive Chairman. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.